[1]魏傲,李强,丁玲,等.参芎注射液对急性非ST段抬高型心肌梗死患者外周血Th17及Treg细胞亚群的影响[J].西部中医药,2022,35(06):107-110.[doi:10.12174/j.issn.2096-9600.2022.06.26]
 WEI Ao,LI Qiang,DING Ling,et al.Effects of Shenxiong Injection on Th17 and Treg Cells Subsets in Peripheral Blood in Patients with Acute Non-ST-Segment Elevation Myocardial Infarction[J].Western Journal of Traditional Chinese Medicine,2022,35(06):107-110.[doi:10.12174/j.issn.2096-9600.2022.06.26]
点击复制

参芎注射液对急性非ST段抬高型心肌梗死患者外周血Th17及Treg细胞亚群的影响
分享到:

《西部中医药》[ISSN:2096-9600/CN:62-1204/R]

卷:
35
期数:
2022年06期
页码:
107-110
栏目:
临证经验
出版日期:
2022-06-15

文章信息/Info

Title:
Effects of Shenxiong Injection on Th17 and Treg Cells Subsets in Peripheral Blood in Patients with Acute Non-ST-Segment Elevation Myocardial Infarction
作者:
魏傲1 李强1 丁玲1 谭宪1 郑曦1 辜琴1 郭东梅1 罗晓丽2
1.重庆市南川区人民医院,重庆 408400
2.陆军军医大学大坪医院
Author(s):
WEI Ao1 LI Qiang1 DING Ling1 TAN Xian1 ZHENG Xi1 GU Qin1 GUO Dongmei1 LUO Xiaoli2
1.The People′s Hospital of Nanchuan, Chongqing 408400, China
2.Daping Hospital & Institute of Surgery Research, Army Medical University (The Third Military Medical University)
关键词:
心肌梗死非ST段抬高型急性参芎注射液辅助性T细胞17调节性T细胞
Keywords:
myocardial infarction non-ST-segment elevation acuteinjectionTh17Treg
分类号:
R542.2+2
DOI:
10.12174/j.issn.2096-9600.2022.06.26
文献标志码:
B
摘要:
目的观察参芎注射液对急性非ST段抬高型心肌梗死(non ST segment elevation myocardial infarction,NSTEMI)患者外周血辅助性T细胞(T helper cell 17,Th17)及调节性T细胞(regulatory T cells,Treg)细胞亚群的影响。 方法选择150例NSTEMI患者,根据随机数字表法将其分为观察组和对照组,每组75例。对照组给予常规治疗,观察组在对照组治疗基础上静脉滴注参芎注射液,疗程为2周。比较两组外周血Th17及Treg细胞亚群,相关炎性细胞因子[白细胞介素6(interleukin-6,IL-6)、白细胞介素17(interleukin-17,IL-17)、转化生长因子β(transforming growth factor-β,TGF-β)]水平,心功能情况[左室舒张末期直径(left ventricular end diastolic diameter,LVEDD)、左心室射血分数(left ventricular ejection fraction,LVEF)、舒张早期充盈峰速度与舒张晚期充盈峰速度的比值(E/A比值)]、临床疗效及不良反应发生情况。 结果与治疗前比较,两组治疗后外周血Th17细胞、Th17/Treg比值、IL-6及IL-17水平明显降低(P<0.05),其中观察组上述指标降低更明显;而Treg细胞亚群和TGF-β水平明显升高,其中观察组上述指标升高更明显(P<0.05)。观察组总有效率[90.67%(68/75)]显著高于对照组[80.00%(60/75)](P<0.05)。与对照组治疗后比较,观察组LVEDD降低更明显,LVEF升高更明显(P<0.05),而E/A比值两组比较,差异无统计学意义(P>0.05)。两组治疗期间不良反应发生率比较,差异无统计学意义(P>0.05)。 结论参芎注射液可显著改善NSTEMI患者外周血Th17和Treg细胞亚群的失衡状况,发挥抗炎作用,减轻心肌损伤,从而改善心功能。
Abstract:
ObjectiveTo observe the effects of Shenxiong injection on Th17 and Treg cells subsets in peripheral blood in patients suffering NSTEMI. MethodsA total of 150 patients with NSTEMI were chosen, allocated to the observa-tion group and the control group according to random number table method, with 75 cases in each group. The control group accepted conventional therapy, and the observation group intravenous dripping of Shenxiong injection based on therapy the control group accepted, the course was two weeks. To compare Th17 and Treg cells subsets in peripheral blood, the levels of the associated inflammatory cytokines [IL-6, IL-17 and TGF-β], clinical effects, cardiac function [LVEDD, LVEF and E/A ratio], and the incidence of adverse reaction between both groups. ResultsCompared with these indexes before treatment, the levels of Th17 cells, Th17/Treg ratio, IL-6, IL-17 lowered notably in peripheral blood after treatment(P<0.05), among them, the decrease of the indexes above in the observa-tion group was more notable; the levels of Treg cells subsets and TGF-β were elevated notably, among them, the increase of the above indexes in the observation group was more notable (P<0.05). Total effective rate of the observation group was [90.67%(68/75)], notably higher than this [80.00%(60/75)] of the control group (P<0.05). Compared with the control group after treating, the decrease of LVEDD was more notable while the increase of LVEF was more notable in the observation group (P<0.05), and the difference had no statistical meaning in E/A ratio (P>0.05). The difference was insignificant in the incidence of adverse reaction during therapeutic period between both groups (P>0.05). ConclusionShenxiong injection could notably improve the imbalance between Th17 and Treg cells subsets in peripheral blood, develop anti-inflammatory effects, give play to anti-inflammatory effects, reduce myocardial damage, therefore to improve cardiac function.

相似文献/References:

[1]胡兰文,徐盛开,范玲莉.老年人急性心肌梗死的临床特征及中医证型分析[J].西部中医药,2013,26(06):44.
 HU Lanwen,XU Shengkai,FAN Lingli.Clinical Characteristics and Patterns Analysis of Acute Myocardial Infarction in the Elderly[J].Western Journal of Traditional Chinese Medicine,2013,26(06):44.
[2]陈少兰,徐胜珍△.中西医结合护理对急性心肌梗死患者康复效果的影响[J].西部中医药,2014,27(04):129.
 CHEN Shaolan,XU Shengzhen.Influence of Nursing on the Patients with Acute Myocardial Infarction at Recovery Stage by Integrative Medicine[J].Western Journal of Traditional Chinese Medicine,2014,27(06):129.
[3]张艳,孙晓云.自拟益气通脉汤辅助预防心肌梗死后心室重构效果观察[J].西部中医药,2014,27(09):106.
[4]邵建兵,汪燕,王加林.麝香保心丸治疗冠心病急性心肌梗死44例[J].西部中医药,2017,30(12):61.
 SHAO Jianbin,WANG Yan,WANG Jialin.SheXiang BaoXin Pills in Treating 44 Cases of Acute Myocardial Infarction of Coronary Heart Disease[J].Western Journal of Traditional Chinese Medicine,2017,30(06):61.

备注/Memo

备注/Memo:
魏傲(1986—),女,硕士学位,主治医师。研究方向:急性心肌梗死的临床研究。国家自然科学基金(81300197);重庆市南川区科技计划项目(Cx2019003)。
更新日期/Last Update: 2022-06-24